DK1542729T3 - Stabilt immunogent produkt omfattende antigene heterokomplekser - Google Patents
Stabilt immunogent produkt omfattende antigene heterokomplekserInfo
- Publication number
- DK1542729T3 DK1542729T3 DK03772373.1T DK03772373T DK1542729T3 DK 1542729 T3 DK1542729 T3 DK 1542729T3 DK 03772373 T DK03772373 T DK 03772373T DK 1542729 T3 DK1542729 T3 DK 1542729T3
- Authority
- DK
- Denmark
- Prior art keywords
- immunogenic product
- stable immunogenic
- antigenic heterocomplexes
- heterocomplexes
- antigenic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6075—Viral proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/622—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier non-covalent binding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/6415—Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/643—Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0211455A FR2844514B1 (fr) | 2002-09-16 | 2002-09-16 | Produit immunogene stable comprenant des heterocomplexes antigeniques, compositions les contenant et procede de preparation |
PCT/FR2003/002733 WO2004024189A1 (fr) | 2002-09-16 | 2003-09-16 | Produit immunogene stable comprenant des heterocomplexes antigeniques |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1542729T3 true DK1542729T3 (da) | 2014-02-10 |
Family
ID=31897411
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK03772373.1T DK1542729T3 (da) | 2002-09-16 | 2003-09-16 | Stabilt immunogent produkt omfattende antigene heterokomplekser |
Country Status (13)
Country | Link |
---|---|
US (3) | US7972603B2 (da) |
EP (1) | EP1542729B1 (da) |
JP (2) | JP4698223B2 (da) |
CN (1) | CN1723041B (da) |
AU (1) | AU2003279427B2 (da) |
BR (1) | BRPI0314373B8 (da) |
CA (1) | CA2499214C (da) |
DK (1) | DK1542729T3 (da) |
ES (1) | ES2445331T3 (da) |
FR (1) | FR2844514B1 (da) |
NZ (1) | NZ538835A (da) |
WO (1) | WO2004024189A1 (da) |
ZA (1) | ZA200502184B (da) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101495645B (zh) * | 2005-03-23 | 2012-08-22 | 生物-拉德实验室公司 | 蛋白纯化方法 |
WO2007022813A2 (en) * | 2005-05-24 | 2007-03-01 | Neovacs | A METHOD FOR PREPARING A STABLE IMMUNOGENIC PRODUCT COMPRISING ANTIGENIC HETEROCOMPLEXES OF TNFα AND A CARRIER PROTEIN |
ATE432955T1 (de) | 2005-12-05 | 2009-06-15 | Nitto Denko Corp | Polyglutamat-aminosäure-konjugate und verfahren |
AU2007259329A1 (en) * | 2006-05-12 | 2007-12-21 | Farris, Darise | Anthrax compositions and methods of use and production |
CN110064053A (zh) * | 2006-08-07 | 2019-07-30 | 哈佛大学校长及研究员协会 | 蛋白质基质疫苗及这种疫苗的制备和给药方法 |
US20080181852A1 (en) * | 2007-01-29 | 2008-07-31 | Nitto Denko Corporation | Multi-functional Drug Carriers |
CN101674852A (zh) * | 2007-04-10 | 2010-03-17 | 日东电工株式会社 | 多功能聚谷氨酸盐药物载体 |
ES2430380T3 (es) * | 2007-05-09 | 2013-11-20 | Nitto Denko Corporation | Composiciones que incluyen un compuesto hidrófobo y un conjugado de poliaminoácido |
CU23652A1 (es) * | 2007-06-29 | 2011-05-27 | Centro Inmunologia Molecular | Composición vacunal homogénea para el tratamiento del cáncer y su método de obtención |
CA2716662A1 (en) * | 2008-03-06 | 2009-03-11 | Nitto Denko Corporation | Polymer paclitaxel conjugates and methods for treating cancer |
CN102008719A (zh) * | 2010-12-02 | 2011-04-13 | 上海微球生物科技有限公司 | 克服b细胞免疫耐受的免疫微球及其应用 |
AU2011340477A1 (en) | 2010-12-08 | 2013-06-20 | Neovacs | Strongly inactivated and still highly immunogenic vaccine and process of manufacturing thereof |
EP2462950A1 (en) | 2010-12-08 | 2012-06-13 | Neovacs | Strongly inactivated and still highly immunogenic vaccine, and process of manufacturing thereof |
EP2694094B1 (en) | 2011-04-07 | 2017-08-16 | Neovacs | METHOD FOR TREATING IFNalpha RELATED CONDITIONS |
EP2861485A4 (en) | 2012-06-13 | 2016-03-02 | Auto Res Ct Llc | POSITIVE CONVERGENCE DEVICE FOR A VEHICLE |
US9199673B2 (en) | 2012-10-30 | 2015-12-01 | Wabash National, L.P. | Aerodynamic rear drag reduction system for a trailer |
US8973974B2 (en) * | 2013-04-30 | 2015-03-10 | Wabash National, L.P. | Aerodynamic rear fairing system for a trailer |
US9409609B2 (en) | 2014-03-24 | 2016-08-09 | Auto Research Center, Llc | Wake convergence device for a pick-up truck |
US9616944B2 (en) | 2014-05-15 | 2017-04-11 | Wabash National, L.P. | Aerodynamic rear drag reduction system for a trailer |
MX368079B (es) | 2015-02-16 | 2019-09-18 | Wabash National Lp | Sistema de reduccion de resistencia aerodinamica posterior para un remolque. |
US9776674B2 (en) | 2015-04-29 | 2017-10-03 | Wabash National, L.P. | Aerodynamic rear drag reduction system for a trailer |
US9834262B2 (en) | 2015-04-29 | 2017-12-05 | Wabash National, L.P. | Aerodynamic rear drag reduction system for a trailer |
CN108289909A (zh) * | 2015-10-19 | 2018-07-17 | 巴尔的摩马里兰大学 | 用于产生工程改造的人原代血液树突细胞系的方法 |
CN108752480B (zh) * | 2018-05-30 | 2022-03-29 | 中元汇吉生物技术股份有限公司 | 一种免疫原组合物、其制备方法及其用途 |
MX2021001479A (es) * | 2018-08-07 | 2021-04-28 | Glaxosmithkline Biologicals Sa | Novedosos procesos y vacunas. |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US98203A (en) * | 1869-12-21 | Improvement in elevators | ||
FR2635532B1 (fr) | 1988-07-29 | 1992-05-22 | Pasteur Institut | Particules hbsag recombinantes hybrides : caracteristiques morphologiques de l'antigene hbsag contenant 1 sequence immunogene induisant des anticorps neutralisants diriges contre hiv ou susceptible d'etre reconnue par de tels anticorps; sequences nucleotidiques codant pour de telles particules; vaccins les contenant |
US5008116A (en) * | 1988-11-14 | 1991-04-16 | Frederick Cahn | Immunostimulatory microsphere |
SE467542B (sv) * | 1989-06-13 | 1992-08-03 | Syntello Ab | Syntetiska peptidantigener, immuniserande komposition och immunanalys foer htlv-1 antikroppar |
JPH04506662A (ja) * | 1989-07-14 | 1992-11-19 | アメリカン・サイアナミド・カンパニー | 接合体ワクチンのためのサイトカイニンおよびホルモンのキヤリヤー |
FR2677654B1 (fr) * | 1991-06-17 | 1995-11-17 | Pasteur Merieux Serums Vacc | Composes a effet immunogene anti-cytokine, a effet immunogene anticytostatique ou a effet vaccinal anti-infection a hiv. |
EP0814834B2 (fr) | 1995-03-08 | 2009-03-18 | Neovacs | Immunogenes denues de toxicite derivant d'une proteine de regulation retrovirale, anticorps diriges contre ces immunogenes, procede pour leur preparation et compositions pharmaceutiques les renfermant |
FR2731355B1 (fr) * | 1995-03-08 | 1997-05-30 | Neovacs | Nouveaux immunogenes, nouveaux anticorps, procede de preparation et compositions pharmaceutiques les renfermant |
US6093045A (en) * | 1996-03-13 | 2000-07-25 | Osram Sylvania Inc. | Electrical connector module and kit having tamper proof latch mechanism |
WO1998026747A2 (en) * | 1996-12-17 | 1998-06-25 | Terman David S | Superantigen based methods and compositions for treatment of diseases |
FR2759296B1 (fr) * | 1997-02-07 | 1999-04-09 | Commissariat Energie Atomique | Complexe non-covalent comprenant au moins un anticorps et un element de liaison aux immunoglobulines associe a une substance active, son procede de preparation et ses applications |
BR9811462A (pt) * | 1997-04-15 | 2000-09-12 | Ferring Farma Lab | Moléculas de tnfalfa modificadas, dna que codifica tais moléculas de tnfalfa modificadas e vacinas que compreendem tais tnfalfa modificadas e dna. |
JP3591264B2 (ja) * | 1997-12-24 | 2004-11-17 | 富士レビオ株式会社 | Vegf121特異的モノクローナル抗体及び測定方法 |
JP2002514573A (ja) * | 1998-05-08 | 2002-05-21 | スローン − ケッタリング インスティチュート フォー キャンサー リサーチ | 能動的なワクチン接種のための組成物および方法 |
FR2781158B1 (fr) * | 1998-07-15 | 2002-12-13 | Vacs Internat | Nouvelles proteines modifiees immunogenes non immunosuppressives, leur procede de preparation et leurs applications |
FR2792639B1 (fr) * | 1999-04-26 | 2003-06-06 | Neovacs | Nouveaux immunogenes anti-vih (toxoides), nouveaux procedes de preparation et application a la prevention et au traitement du sida |
AU767390B2 (en) * | 1999-05-13 | 2003-11-06 | Agriculture Victoria Services Pty Ltd | (lawsonia) derived gene and related OmpH polypeptides, peptides and proteins and their uses |
FR2812813B1 (fr) * | 2000-08-09 | 2004-11-26 | Neovacs | Utilisation d'immunogenes pour traiter ou prevenir au sein des tumeurs malignes les dereglements immunitaires induits par des facteurs extracellulaires |
AUPR011700A0 (en) * | 2000-09-14 | 2000-10-05 | Austin Research Institute, The | Composition comprising immunogenic virus sized particles (VSP) |
AU2001294458B2 (en) * | 2000-10-06 | 2004-03-11 | Jagotec Ag | Biodegradable microparticles for controlled release administration, with purified amylopectin-based starch of reduced molecular weight |
-
2002
- 2002-09-16 FR FR0211455A patent/FR2844514B1/fr not_active Expired - Fee Related
-
2003
- 2003-09-16 CA CA2499214A patent/CA2499214C/fr not_active Expired - Lifetime
- 2003-09-16 ES ES03772373.1T patent/ES2445331T3/es not_active Expired - Lifetime
- 2003-09-16 AU AU2003279427A patent/AU2003279427B2/en not_active Expired
- 2003-09-16 DK DK03772373.1T patent/DK1542729T3/da active
- 2003-09-16 CN CN038251477A patent/CN1723041B/zh not_active Expired - Lifetime
- 2003-09-16 US US10/527,975 patent/US7972603B2/en not_active Expired - Lifetime
- 2003-09-16 BR BRPI0314373A patent/BRPI0314373B8/pt active IP Right Grant
- 2003-09-16 NZ NZ538835A patent/NZ538835A/en not_active IP Right Cessation
- 2003-09-16 EP EP03772373.1A patent/EP1542729B1/fr not_active Expired - Lifetime
- 2003-09-16 JP JP2004535614A patent/JP4698223B2/ja not_active Expired - Lifetime
- 2003-09-16 WO PCT/FR2003/002733 patent/WO2004024189A1/fr active Application Filing
-
2005
- 2005-03-15 ZA ZA2005/02184A patent/ZA200502184B/en unknown
- 2005-05-24 US US11/135,660 patent/US8372388B2/en active Active
-
2010
- 2010-10-19 JP JP2010234523A patent/JP2011012084A/ja active Pending
-
2011
- 2011-05-31 US US13/149,041 patent/US8697047B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
BR0314373A (pt) | 2005-07-19 |
CN1723041B (zh) | 2012-07-18 |
CA2499214C (fr) | 2014-02-11 |
ES2445331T3 (es) | 2014-03-03 |
WO2004024189A1 (fr) | 2004-03-25 |
ZA200502184B (en) | 2005-12-28 |
EP1542729B1 (fr) | 2013-11-06 |
EP1542729A1 (fr) | 2005-06-22 |
US7972603B2 (en) | 2011-07-05 |
JP4698223B2 (ja) | 2011-06-08 |
JP2006504689A (ja) | 2006-02-09 |
US20060067944A1 (en) | 2006-03-30 |
US20110250174A1 (en) | 2011-10-13 |
JP2011012084A (ja) | 2011-01-20 |
FR2844514A1 (fr) | 2004-03-19 |
US8372388B2 (en) | 2013-02-12 |
US8697047B2 (en) | 2014-04-15 |
CA2499214A1 (fr) | 2004-03-25 |
BRPI0314373B8 (pt) | 2021-05-25 |
US20060013800A1 (en) | 2006-01-19 |
FR2844514B1 (fr) | 2007-10-19 |
NZ538835A (en) | 2006-07-28 |
AU2003279427B2 (en) | 2008-12-18 |
BRPI0314373B1 (pt) | 2019-11-05 |
AU2003279427A1 (en) | 2004-04-30 |
CN1723041A (zh) | 2006-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1542729T3 (da) | Stabilt immunogent produkt omfattende antigene heterokomplekser | |
IS7547A (is) | Ónæmisvaldandi samsetningar | |
ATE388643T1 (de) | Rauchloses tabakerzeugnis | |
PT1501534E (pt) | Formulacoes farmaceuticas | |
CY2013036I2 (el) | Συνθεσεις εμβολιου κατα της ναϊσσερια, που περιεχουν εναν συνδυασμο αντιγονων | |
IS7831A (is) | Bóluefni | |
NO20035208D0 (no) | Nytt vaksine preparat | |
ATE387214T1 (de) | Impfstoff gegen bakterielle antigene | |
DK1228217T3 (da) | Konserverede neisseria-antigener | |
CY2012030I1 (el) | Πολυδυναμο εμβολιο προϊοντος συζευξης μηνιγγοκοκκικου πολυσακχαριδιου-πρωτεϊνης | |
DE60222056D1 (de) | Hebestuhl | |
NO20033556L (no) | Farmasöytiske formuleringer | |
NO20031483D0 (no) | Vaksine | |
IS8387A (is) | Ónæmisvaldandi samsetningar | |
NO20024172L (no) | Vaksine | |
IS7564A (is) | Lyfjablanda með breytta losun | |
NO20033882L (no) | Vaksine | |
DE60238075D1 (de) | Adjuvierte antigene meningokokkenzusammensetzungen | |
ATE290845T1 (de) | Selbstschäumendes kosmetisches produkt | |
DK1539089T3 (da) | Reducerede aerosol-genererende formuleringer | |
IS2922B (is) | Bóluefni | |
AU2003282498A8 (en) | Hiv vaccine formulations | |
DE60328408D1 (de) | Impfstoff | |
ES1050889Y (es) | Articulo para masticar | |
ITVI20020019A1 (it) | Sedia elettrostatica |